The total synthesis of the anti-cancer drug paclitaxel (Taxol) was achieved by Robert Holton in 1994, marking a significant milestone in pharmaceutical chemistry. This accomplishment demonstrated the potential for synthesizing complex natural products, leading to advancements in cancer treatment. Taxol has since become a crucial drug in oncology, highlighting the importance of synthetic chemistry in medicine.

The first synthesis of Taxol in 1994 highlighted the significance of nature-derived medicines, informing eco-poetry and narratives of healing. Poets began to explore the intersection of science and nature, reflecting on the human experience of illness and recovery.